Get started
MIRA Pharmaceuticals, Inc.MIRA Pharmaceuticals, Inc.MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MIRA chart


Full chart

MIRA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪24.98 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.84 USD
Net income (FY)
‪−11.98 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪9.96 M‬
Beta (1Y)
−2.47

Employees


Employees (FY)
3
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−3.99 M‬ USD

About MIRA Pharmaceuticals, Inc.


Sector
Health Technology
CEO
Erez Aminov
Headquarters
Miami
Website
mirapharmaceuticals.com
Founded
2020
FIGI
BBG01H8XP5F5
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company engages in developing its product candidate, MIRA1a, as a synthetic cannabinoid analog for treating anxiety & chronic pain by targeting the cannabinoid type 1 and type 2 (CB1 and CB2) receptors. MIRA Pharmaceuticals was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MIRA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MIRA is 1.59 USD — it has decreased by −0.59% in the past 24 hours. Watch MIRA Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MIRA Pharmaceuticals, Inc. stocks are traded under the ticker MIRA.
MIRA stock has fallen by −26.52% compared to the previous week, the month change is a 52.25% rise, over the last year MIRA Pharmaceuticals, Inc. has showed a −2.45% decrease.
We've gathered analysts' opinions on MIRA Pharmaceuticals, Inc. future price: according to them, MIRA price has a max estimate of 17.75 USD and a min estimate of 7.50 USD. Watch MIRA chart and read a more detailed MIRA Pharmaceuticals, Inc. stock forecast: see what analysts think of MIRA Pharmaceuticals, Inc. and suggest that you do with its stocks.
MIRA reached its all-time high on Aug 3, 2023 with the price of 7.98 USD, and its all-time low was 0.51 USD and was reached on Jul 3, 2024. View more price dynamics on MIRA chart.
See other stocks reaching their highest and lowest prices.
MIRA stock is 11.58% volatile and has beta coefficient of −2.47. Track MIRA Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is MIRA Pharmaceuticals, Inc. there?
Yes, you can track MIRA Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
MIRA Pharmaceuticals, Inc. is going to release the next earnings report on Nov 27, 2024. Keep track of upcoming events with our Earnings Calendar.
MIRA earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.11 USD resulting in a 2.94% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about MIRA Pharmaceuticals, Inc. earnings.
MIRA Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MIRA net income for the last quarter is ‪−1.69 M‬ USD, while the quarter before that showed ‪−1.72 M‬ USD of net income which accounts for 1.54% change. Track more MIRA Pharmaceuticals, Inc. financial stats to get the full picture.
No, MIRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 3.00 employees. See our rating of the largest employees — is MIRA Pharmaceuticals, Inc. on this list?
Like other stocks, MIRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MIRA Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MIRA Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MIRA Pharmaceuticals, Inc. stock shows the sell signal. See more of MIRA Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.